Over the past decade, the healthcare ecosystem has slowly moved toward the “triple aim”: better healthcare experiences, improved outcomes, and a slowing of the growth of overall healthcare costs. While many pharma companies have focused on educating and engaging patients to promote shared decision-making, improved experiences and adherence, and reduced costs, many still struggle to define what patient centricity means or how to link efforts to business results.